Mohammed Sallam

Nov 18, 2024 | radcliffecardiology.com | Harriette Van Spall |Kausik K. Ray |Mohammed Sallam |Derek L Connolly

AHA Conference 2024 — Key findings from the ZODIAC trial investigating the role of a decision support system in optimising lipid-lowering therapy for ACS patients. Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Kausik Ray (Imperial College London, UK) to discuss the findings from the randomized controlled ZODIAC trial assessing decision support systems (DSS) in optimising lipid-lowering therapies in patients with acute coronary syndrome (ACS).

Aug 22, 2023 | gulfnews.com | Mohammed Sallam

Mediclinic Parkview Hospital in Dubai is proud to share that it has become the first hospital in the UAE to offer Tofersen, a revolutionary therapy for an ultra-rare subset of Amyotrophic Lateral Sclerosis (ALS), Superoxide Dismutase 1 (SOD1) gene mutation-mediated ALS. Dr Fatmah Al Zahmi, Consultant Neurologist at Mediclinic Parkview Hospital, Dubai, explains, “ALS is a debilitating neurodegenerative disease that affects thousands of individuals worldwide.